A potent FGFR4-targeted antibody-drug conjugate therapy for patients with rhabdomyosarcoma and other cancers expressing FGFR4

被引：0
|
作者：
Tian, Meijie
Jia, Katrina
Wu, Jerry T.
Wei, Jun S.
Cheuk, Adam T.
Zhang, Zhongmei
Pope, Eleanor G.
Shor, Boris
Tumey, L. Nathan
Khan, Javed
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2024-LB042
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB042
引用
收藏
页数：3
相关论文
共 50 条
  • [41] XMT-1660, a B7-H4-targeted Dolasynthen antibody-drug conjugate for the treatment of breast cancer.
    Fessler, Shawn P.
    Wang, Jason
    Collins, Scott D.
    Qin, LiuLiang
    Avocetien, Kenneth
    Xu, Ling
    Eydelloth, Ronald
    Vonderfecht, Steven
    Chin, Chen-Ni
    Bradley, Steven
    Clardy, Susan
    Dirksen, Anouk
    Ditty, Elizabeth
    Du, Bingfan
    Kim, Dokyong
    Mosher, Rebecca
    Ter-Ovanesyen, Elena
    Slocum, Kelly
    Uttard, Alex
    Wongthida, Phonphimon
    Zurita, Jeffrey
    Toader, Dorin
    Damelin, Marc
    Lowinger, Timothy B.
    CANCER RESEARCH, 2021, 81 (13)
  • [42] Antibody-drug Conjugate PCMC1D3-Duocarmycin SA as a Novel Therapeutic Entity for Targeted Treatment of Cancers Aberrantly Expressing MET Receptor Tyrosine Kinase
    Hudson, Rachel
    Yao, Hang-Ping
    Suthe, Sreedhar Reddy
    Patel, Dhavalkumar
    Wang, Ming-Hai
    CURRENT CANCER DRUG TARGETS, 2022, 22 (04) : 312 - 327
  • [43] Discovery and development of BLU-554: A potent, highly selective covalent inhibitor of Fibroblast Growth Factor Receptor 4 (FGFR4) in development for the targeted treatment of advanced Hepatocellular Carcinoma (HCC) patients with amplified and overexpressed FGF19
    Miduturu, Chandra
    Hagel, Margit
    Sheets, Mike
    Rubin, Nooreen
    Weng, Weifan
    Bifulco, Neil
    Dipietro, Lucian
    Kim, Joseph
    Brooijmans, Natasja
    Hodous, Brian
    Stransky, Nico
    Hoeflich, Klaus
    Kadambi, Vivek
    Kohl, Nancy
    Lengauer, Christoph
    Guzi, Timothy
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [44] A phase I, first-in-human study of TAK-164, an antibody-drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase C
    Kim, Richard
    Leal, Alexis D.
    Parikh, Aparna
    Ryan, David P.
    Wang, Shining
    Bahamon, Brittany
    Gupta, Neeraj
    Moss, Aaron
    Pye, Joanna
    Miao, Harry
    Inguilizian, Haig
    Cleary, James M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2023, 91 (04) : 291 - 300
  • [45] Discovery and Preclinical Characterization of XMT-1660, an Optimized B7-H4-Targeted Antibody-Drug Conjugate for the Treatment of Cancer
    Toader, Dorin
    Fessler, Shawn P.
    Collins, Scott D.
    Conlon, Patrick R.
    Bollu, Reddy
    Catcott, Kalli C.
    Chin, Chen-Ni
    Dirksen, Anouk
    Du, Bingfan
    Duvall, Jeremy R.
    Higgins, Stacy
    Kozytska, Mariya V.
    Bellovoda, Kamela
    Faircloth, Chelsey
    Lee, David
    Li, Fu
    Qin, Liuliang
    Routhier, Caitlin
    Shaw, Pamela
    Stevenson, Cheri A.
    Wang, Jason
    Wongthida, Phonphimon
    Ter-Ovanesyan, Elena
    Ditty, Elizabeth
    Bradley, Stephen P.
    Xu, Ling
    Yin, Mao
    Yurkovetskiy, Alexandr V.
    Mosher, Rebecca
    Damelin, Marc
    Lowinger, Timothy B.
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (09) : 999 - 1012
  • [46] A novel 5T4-targeting antibody-drug conjugate H6-DM4 exhibits potent therapeutic efficacy in gastrointestinal tumor xenograft models
    Wang, Ruixue
    Lai, Qinhuai
    Tang, Liangze
    Tao, Yiran
    Yao, Yuqin
    Liu, Yu
    Lu, Ying
    Shen, Chaoyong
    Lu, Ran
    Fan, Chuanwen
    Zhang, Ruirui
    Wang, Yuxi
    Yu, Lin
    Yang, Tinghan
    Wu, Yangping
    Peng, Yujia
    Wei, Xian
    Fu, Yuyin
    Lai, Weirong
    Gou, Lantu
    Yang, Jinliang
    AMERICAN JOURNAL OF CANCER RESEARCH, 2018, 8 (04): : 610 - +
  • [47] A Novel Antibody-Drug Conjugate (ADC) Delivering a DNA Mono-Alkylating Payload to Chondroitin Sulfate Proteoglycan (CSPG4)-Expressing Melanoma
    Hoffmann, Ricarda M.
    Crescioli, Silvia
    Mele, Silvia
    Sachouli, Eirini
    Cheung, Anthony
    Chui, Connie K.
    Andriollo, Paolo
    Jackson, Paul J. M.
    Lacy, Katie E.
    Spicer, James F.
    Thurston, David E.
    Karagiannis, Sophia N.
    CANCERS, 2020, 12 (04)
  • [48] A Breath of Fresh Air: Grade 4 Pneumonitis Secondary to HER2 Antibody-Drug Conjugate Therapy Treated with Plasma Exchange
    Teng, Christina
    Wei, Joe Q.
    Killen, Andrew
    Thirumaran, Aricia
    Lemech, Charlotte R.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2024, 20 : 60 - 61
  • [49] LNCB74 is a potent and safe next-generation antibody-drug-conjugate utilizing a cancer selective linker for the treatment of B7-H4 expressing cancers
    Fitzgerald, Daniel P.
    Doan, Duc N.
    Peacock, Riley B.
    Kahan, Shannon M.
    Lomash, Suvendu
    Slocum, Stephen
    Jung, Kwang Hwa
    Oh, Hwanhee
    Meza, Ingrid
    Manzanarez, Yanira
    Selvam, Shanmugam
    Flies, Dallas B.
    Chung, Chul-Woong
    Langermann, Sol
    CANCER RESEARCH, 2024, 84 (06)
  • [50] NGM282 Induces Low Density Lipoprotein Cholesterol (LDLc) Changes, Consistent with Potent FGFR4 Signaling, which are Rapidly Mitigated with Statin Therapy in Patients with Biopsy-Confirmed Nonalcoholic Steatohepatitis (NASH)
    Rinella, Mary E.
    Trotter, James F.
    Neff, Guy
    Ortiz-Lasanta, Grisell
    Abdelmalek, Manal F.
    Kugelmas, Marcelo
    Paredes, Angelo H.
    Connelly, Margery A.
    Ling, Lei
    Rossi, Stephen J.
    DePaoli, Alex M.
    Loomba, Rohit
    Harrison, Stephen A.
    HEPATOLOGY, 2017, 66 : 1132A - 1133A
12345